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A B S T R A C T
Purpose: The aim of this study was to detect clinical variables associated with the extent of change of the
irritative zone in benign epilepsy of childhood with centrotemporal spikes (BECTS) after oxcarbazepine
monotherapy.
Method: BECTS patients receiving oxcarbazepine monotherapy were retrospectively reviewed. Changes
in current-source density (CSD) of the maximum negative points of interictal spikes prior to the start of
oxcarbazepine treatment were compared with CSD following oxcarbazepine treatment for 6–12 months.
CSD was measured using low-resolution brain electromagnetic tomography (LORETA). Patients were
divided into two groups based on the change in CSD: increased-extent or decreased-extent. Comparisons
were made between the groups based on the age of onset, seizure frequency before treatment, time
interval between seizure onset and treatment start, time interval between the two EEGs, oxcarbazepine
dosage at the follow-up electroencephalography, occurrence of daytime seizures, and seizure control.
Results: Fourteen patients were enrolled. Seven patients were in the decreased-extent group and six in
the increased-extent group; one patient was excluded because she did not demonstrate any change in
CSD. We found that seizure control differed signiﬁcantly between the two groups: seizures were well-
controlled in six out of seven patients in the decreased-extent group (85.7%), but in only one of six
patients (16.7%) in the increased-extent group (p = 0.03). The other variables did not differ between the
groups.
Conclusion: Seizure control may be associated with the extent of changes in the neuronal irritative zones
of BECTS patients. We suggest that changes of CSD extent may be used as an imaging modality to
evaluate clinical improvement in BECTS patients.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Benign epilepsy of childhood with centrotemporal spikes
(BECTS) is the most common idiopathic childhood focal epilepsy.1
Morphologically similar centrotemporal spikes may be observed in
various other clinical syndromes,2 but the electroencephalograph-
ic (EEG) ﬁnding of centrotemporal spikes plays a decisive role in
the diagnosis of BECTS in children with normal neurodevelop-
ment.3 Centrotemporal spikes are characterized by focal surface* Corresponding author at: Department of Neurology, Gyeongsang National
University School of Medicine, 79 Gangnam-ro, Jinju 660-702, Republic of Korea.
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1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights renegative spikes with relatively prolonged duration, high ampli-
tude, and bluntness.4 These spike characteristics suggest that
BECTS are generated by an extensive neuronal pool4 and possesses
relatively low epileptogenicity.5
Although the interictal spikes in BECTS have distinctive
neurophysiological characteristics, the relationship between
these discharges and the degree of seizure-control in a particular
patient has yet to be clariﬁed.4 Furthermore, no correlation has
been noted between the intensity of spike discharges in the EEG
and the frequency, length, or duration of clinical seizures; or
between an atypical morphology of interictal spikes and seizure
frequency in previous studies.6–8 In particular, the persistence of
EEG abnormalities long after clinical seizure remission and
extreme discrepancies characterized by very rare seizures on
the one hand but high EEG activity on the other common. Clinicalserved.
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unchanged even after treatment has effectively stopped sei-
zures.1,9 These ﬁndings suggest that it is difﬁcult to anticipate the
clinical manifestations of BECTS based on the visual character-
istics of interictal spikes. Having said that, a computer-based
assessment10 of interictal spikes in childhood partial seizures,
including BECTS, demonstrated that the achievement of seizure
control using antiepileptic medication is associated with changes
in epileptic spike conﬁguration, including decreases in spike
amplitude and duration. The authors hypothesized that such
changes in spike morphology may be caused by critical reductions
in the epileptogenic neuronal pool, however they did not have the
proper instruments to demonstrate this.10
Since that study was published, remarkable advances in
functional imaging techniques have been made, and researchers
now have the ability to observe neuronal activity and obtain 3-
dimensional data in a non-invasive manner, for instance by using
EEG current-source analysis. Low-resolution brain electromagnet-
ic tomography (LORETA) is one of these functional imaging
methods. It uses EEG measurements based on electrophysiological
and neuroanatomical constraints.11 LORETA can demonstrate 3-
dimensional distributions of electrical neuronal activity, with
maximum similarities of orientation and strength between
neighboring neuronal populations.11 Therefore, it may be an
excellent tool for investigating the epileptogenic neuronal pools
that correspond to interictal epileptic abnormalities. To date there
are only few studies investigating the electrophysiological
characteristics of BECTS using current-source analyses of EEG,
and a current-source analysis using LORETA may be helpful for
investigating the relationship between current-source changes of
interictal spikes and seizure control. Thus, the purpose of this study
was to investigate the relationship between distributional changes
in irritative neuronal areas and seizure control in BECTS patients. A
number of clinical factors were also analyzed to evaluate whether
these factors are inﬂuenced by the extent of change in the irritative
area following treatment.
2. Methods
2.1. Subjects
Children, newly diagnosed with epilepsy, who met the diagnostic
criteria for BECTS, were recruited retrospectively from January 2009
to August 2013 at Gyeongsang National University Hospital. The
diagnosis of BECTS was based on the following criteria: seizure onset
between the ages of 4 and 14 years, blunt high-voltage centro-
temporal or mid-temporal spikes or sharp-wave focus on EEG scans,
a normal neurological examination, the absence of brain lesions and
compatible seizure semiology. Of the newly diagnosed BECTS
patients, only those who had undergone at least two EEG recordings
were included in the study: the ﬁrst EEG immediately following the
diagnosis of BECTS and the start of oxcarbazepine (OXC) mono-
therapy (baseline) and the second EEG during the maintenance
phase of treatment, 6–12 months after drug initiation (post-
treatment). To minimize the effect associated with the use of
different antiepileptic drugs (AED), only BECTS patients undergoing
OXC monotherapy were included. Patients were excluded if (1) there
was inadequate data, or they were unavailable for follow-up, (2)
they experienced breakthrough seizures due to low compliance with
OXC, (3) they were receiving polytherapy or taking AEDs other than
OXC, or (4) they had an inadequate EEG follow-up interval.
During the study period, a total of 28 patients were newly
diagnosed with BECTS. Within this group, 14 patients were
excluded for different reasons (1) unavailability for follow-up
(n = 4); (2) breakthrough seizures due to poor compliance with
OXC treatment (n = 3); (3) polytherapy or AED medication otherthan OXC (n = 3); and (4) inadequate EEG follow-up interval (n = 4).
Ultimately, 14 patients were enrolled in the study.
2.2. EEG recording
EEG recordings were taken for a minimum of 30 min in each
patient, with the majority of recordings obtained during the
waking state. A 32-channel digital EEG machine (Comet1 EEG
machine; Grass-Telefactor; West Warwick, Rhode Island, USA) was
used in conjunction with 25 electrodes placed on the scalp
according to the International 10-20 System (Fp1, Fp2, F3, F4, C3,
C4, P3, P4, O1, O2, F7, F8, T7, T8, P7, P8, F9, F10, T9, T10, P9, P10, Fz,
Cz, and Pz). The sampling rate was 400 Hz, and two EEGs from each
patient were analyzed.
2.3. EEG analysis using LORETA
Brain Electrical Source Analysis (BESA; V. 5.1; MEGIS; Grafelf-
ing, Germany) software was used to select epochs for data
processing. After the visual selection of typical interictal spikes, 20
EEG segments of 1 s epochs, including 500 ms before and 500 ms
after the maximum positive point of the spikes, were obtained.
These 20 epochs were averaged to one spike for each set of EEG
data in each patient. Thus, one averaged spike was obtained from
the baseline EEG, and another was obtained from the post-
treatment EEG for each patient.
Two LORETA images corresponding to the positive peak of the
averaged spikes were obtained from each patient to identify the
anatomical distribution and extent of the current source of the
averaged spikes. LORETA is a distributed model that adapts a depth
weighting to compensate for the drawbacks of the minimal norm
approach.11,12 The area with the highest current density is the
location of current source.13 To objectively deﬁne the distribution
of the current source, percentiles were used to determine the
threshold of signiﬁcance. Because the probability distribution for
the current source suggested that the 95th percentile would be
reasonable, a current-source distribution over the 95th percentile
was considered the threshold of signiﬁcance.14 Therefore, we
calculated a LORETA value of mean +2 standard deviations among
all LORETA values in each EEG, and considered this the threshold
value of LORETA images in each EEG. The neuronal cortex has been
modeled as a collection of volume elements (voxels) in the
digitized Talairach atlas (provided by the Brain Imaging Center,
Montreal Neurological Institute), and LORETA represents a total of
2394 voxels at 7-mm spatial resolution.11 For quantitative
analysis, the voxels for the current-source density (CSD) of the
averaged spikes of the baseline and post-treatment EEGs were
enumerated and compared. The complete EEG data were analyzed
by an investigator (SJ). The investigator who undertook the LORETA
analysis did not have access to any clinical information regarding
the patients during the entire analytic process.
2.4. Acquisition of clinical information and statistical analysis
Clinical data were acquired by means of a chart review and
parental documentation. Clinical factors included age of onset,
seizure frequency before treatment, time interval between seizure
onset and treatment start, time interval between the two EEGs,
AED dosage at the follow-up EEG, and seizure control. Seizure
occurrence was measured according to parental documentation,
and seizure frequency at baseline was deﬁned as seizure number
per month. Patients were categorized as ‘‘well-controlled’’ if they
had been seizure-free during the time interval between the
baseline and post-treatment EEGs (at least six months), and as
‘‘poorly-controlled’’ if they had experienced a recurrence of a
seizure or seizures during the same time interval.
Table 2
Comparison of clinical factors between the increased-extent group and the
decreased-extent CSD group.
Decreased-extent
CSD group (n = 7)
Increased-extent
CSD group (n = 6)
pa
Age (years)
Onsetb 9.28  1.70 7.67  2.12 0.18
1st EEGc 9.71  2.06 8.17  2.50 0.30
2nd EEGd 10.60  1.90 9.17  2.50 0.30
Number of females (%) 6 (85.7%) 3 (50.0%) 0.30
Interval between the two
EEGs (months)
10.43  2.07 11.12  1.33 0.63
Baseline seizure frequency
(per month)
1.54  1.05 1.98  1.52 0.37
Time interval from Sz onset
to treatment (month)
5.00  3.91 7.00  4.56 0.45
OXC dosage at the
follow-up EEG (mg/Kg)
13.57  4.76 18.33  5.16 0.14
Number of patients with
good seizure control (%)
6 (85.7%) 1 (16.7%) 0.03
CSD: current source density, EEG: electroencephalography, Sz: seizure, OXC:
oxcarbazepine.
a Mann–Whitney U-test or Fisher’s exact test.
b Age at onset of seizures.
c Age at baseline-EEG performed.
d Age at post-treatment EEG performed.
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extent of change in the voxels of CSD between the two EEGs:
increased extent and decreased extent. One patient was not
included in the factor analysis because there was no change in CSD
between the baseline and post-treatment EEGs. The clinical
variables mentioned above were then compared between the
two groups using a Mann–Whitney U-test for numerical data and a
Fisher’s exact test for categorical data. A p-value less than 0.05 was
considered statistically signiﬁcant. All analyses were performed
using SPSS for Windows version 12.0 (Chicago, IL, USA).
3. Results
3.1. Conventional EEG inspection and current-source analysis
For all patients, the interictal spikes exhibited a centrotemporal,
mid-temporal, or mid-parietal predominance in the right or left
cerebral hemisphere. The CSD of the averaged spikes were
distributed among the middle frontal gyrus, postcentral gyrus,
superior-middle-inferior temporal gyri, insula, fusiform gyrus,
cingulate gyrus, and inferior parietal lobule (Table 1). The primary
CSD regions did not change in any of the patients following OXC
medication, although the extent of the change in CSD differed
between the two sequential EEGs for all patients except Patient 12.
Following the administration of OXC, the number of CSD voxels
decreased in seven patients, increased in six patients, and
remained unchanged in one patient (Table 1). For example, in
Patient 4, the maximal points of CSD were at the superior temporal
gyrus and the middle temporal gyrus of the left hemisphere in the
baseline EEG and at the postcentral gyrus of the same hemisphere
in the follow-up EEG; the number of CSD voxels decreased from
143 to 107 (Fig. 1). In Patient 14, the maximal points of CSD were at
the inferior frontal gyrus, middle temporal gyrus, postcentral
gyrus, and insula of the left hemisphere in the baseline EEG and at
the middle frontal gyrus, middle temporal gyrus, and cuneus of the
same hemisphere in the follow-up EEG; the number of CSD voxels
increased from 108 to 124 (Fig. 2).
3.2. Factors associated with the distributional changes in CSD
Seizure control was signiﬁcantly different between the in-
creased-extent group and the decreased-extent group (p = 0.03).Table 1
Extent of changes in the current-source density of interictal spikes and the seizure con
childhood with centrotemporal spikes.
Patient no. Age (year) Gender CSD (baseline) 
Onseta 1st EEGb 2nd EEGc Maximal points 
1 10 11 12 F MFG, PCeG, PCiG, insula (Rt)
2 8 8 9 M MTG, ITG (Lt) 
3 5 5 6 F STG, ACG, precuneus (Rt) 
4 10 10 11 M STG, MTG (Lt) 
5 6 7 8 M PCeG, insula (Lt) 
6 10 11 12 F STG, IPL, ACG (Lt) 
7 10 10 11 F STG, MTG (Lt) 
8 9 10 11 F IFG, PCeG, insula (Rt) 
9 11 12 12 F IFG, precuneus (Rt) 
10 6 6 7 F STG (Lt) 
11 11 12 13 F MFG, STG, IPL (Lt) 
12 8 9 10 F MTG, IPL (Lt) 
13 8 8 9 F MFG, STG, PCeG, CG (Lt) 
14 7 7 8 M IFG, MTG, PCeG, insula (Lt) 
CSD: current source density, EEG: electroencephalography, F: female, M: male, Lt: left, Rt:
gyrus, MTG: middle temporal gyrus, ITG: inferior temporal gyrus, STG: superior temporal
CG: cingulate gyrus.
a Age at onset of seizures.
b Age at baseline-EEG performed.
c Age at post-treatment EEG performed.Seizures were well-controlled in six patients in the decreased-extent
group (85.7%) but in only one patient (16.7%) in the increased-extent
group (Table 2). The number of CSD voxels remained unchanged in
one patient, who exhibited a poor clinical course; this patient was
excluded from the factor analysis. The age of onset, gender
distribution, interval between the two EEGs, baseline seizure
frequency, interval between seizure onset and medication start,
occurrence of daytime seizures, and OXC dosage at the time of the
follow-up EEG were not signiﬁcantly different between the two
groups.
4. Discussion
The primary ﬁnding of the present study was that the
distribution of CSD of interictal spikes in BECTS patients tended
to decrease when seizures were controlled by OXC. These ﬁndings
also suggest that seizure control may be associated with the extent
of changes in the neuronal irritative zones of BECTS patients. Thetrol status following oxcarbazepine treatment in patients with benign epilepsy of
CSD (after treatment) Seizure control
No. of voxels Maximal points No. of voxels
 126 MFG, PCeG, CG, cuneus (Rt) 119 Good
150 STG, MTG (Lt) 168 Poor
97 STG, ACG, IPL (Rt) 130 Poor
143 PCeG (Lt) 107 Good
104 STG, IPL (Lt) 114 Poor
131 FG, IPL (Lt) 108 Poor
152 MTG, ACG (Lt) 138 Good
104 MFG, STG, IPL (Rt) 118 Poor
136 PCeG (Rt) 107 Good
125 MTG (Lt) 118 Good
104 MTG, PCeG, CG (Lt) 123 Good
149 MTG, IPL (Lt) 149 Poor
118 IFG, STG (Lt) 107 Good
108 MFG, MTG, cuneus (Lt) 124 Poor
 right, MFG: middle frontal gyrus, PCeG: postcentral gyrus, PCiG: posterior cingulate
 gyrus, ACG: anterior cingulate gyrus, IPL: inferior parietal lobule, FG: fusiform gyrus,
Fig. 1. Distribution and extent of change in current-source density (CSD) in a 10-year-old male patient (Patient 4). The maximal points of CSD were at the superior temporal
gyrus and the middle temporal gyrus of the left hemisphere on the baseline EEG and at the postcentral gyrus of the same hemisphere on the follow-up EEG. The number of CSD
voxels decreased from 143 to 107 from baseline to follow-up.
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Fig. 2. Distribution and extent change of current-source density (CSD) in a 7-year-old male patient (Patient 14). The maximal points of CSD were at the inferior frontal gyrus,
middle temporal gyrus, postcentral gyrus, and insula of the left hemisphere on the baseline EEG and the middle frontal gyrus, middle temporal gyrus, and cuneus of the same
hemisphere on the follow-up EEG. The number of CSD voxels increased from 108 to 124 from baseline to follow-up.
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and is associated with the epileptogenic zone. The epileptogenic
zone is a cortical area that would have to be resected or disconnected
to obtain complete seizure control due to its association with the
irritative zone as well as the seizure onset zone, any epileptogenic
lesion, and the functional deﬁcit zone. Although the irritative zone
overlaps with the epileptogenic zone, the entirety of the irritative
zone is not always included in the epileptogenic zone.15 Therefore,
the decrease in the spatial extent of the irritative zone after
achievement of seizure control in this study cannot be considered
direct evidence of a reduction of the epileptogenic zone in BECTS
patients. However, the current results indicate that the extent of
changes observed by LORETA imaging can be used as a biomarker of
clinical improvement in BECTS patients.
It is generally accepted that the frequency and persistence of
interictal spikes do not predict the severity and frequency of
seizures or the prognosis of BECTS patients.16 However, the extent
of the changes in CSD of interictal spikes was associated with the
clinical course of BECTS patients in this study. The pathophysiology
underlying BECTS is thought to be a hereditary impairment of brain
maturation in the lower Rolandic cortex.17 A hyper-excitable
Rolandic cortex tends to mature and stabilize with age.17 The
favorable clinical course of the decreased-extent group following
the use of OXC in this study may reﬂect the progression of cortical
maturation, which may in turn have decreased the extent of the
cortical irritative zone in the patients. The reduced extent of CSD
observed in this study may indicate a decrease in the area of the
irritative zone in BECTS patients. On the other hand, an increase in
the extent of the irritative zone suggests that the timing of
maturation in the hyper-excitable cortex may inherently differ
among individuals or may be actively disturbed in some
individuals. The poor clinical course of the increased-extent group
in this study may suggest that it is difﬁcult to control seizures
during an active period of cortical hyper-excitability.
Several studies have tested whether the extent of EEG
abnormalities seen in BECTS patients represents a risk for multiple
seizures or a reason for polytherapy, but the presence of bilateral
epileptiform activity has not been found to be a risk factor.7,18,19
Although these studies analyzed only the bilaterality of centro-
temporal spikes, the ﬁndings support the concept that the
characteristics of interictal spikes in BECTS patients do not predict
their prognosis. A recent study,20 however, did identify a possible
relationship between EEG abnormalities and the prognosis of
BECTS. In that study, patients with atypical benign partial epilepsy
(ABPE) that evolved from BECTS exhibited extended periods of
high-frequency spikes with a frontal focus.20 The authors20
suggested that the characteristics of these EEG abnormalities in
ABPE patients may be associated with disturbances of brain
maturation. By the same token, the increased extent of CSD
observed in the EEG data from the current study may suggest
disturbances in brain maturation and a risk for BECTS patients to
develop ABPE. CSD analysis with sequential EEGs could be used to
observe progression of brain maturation and predict the prognosis
of BECTS patients.
Another question of interest is whether responsiveness to OXC
inﬂuences the extent of changes in CSD and alters the course of the
disease. Most AEDs seem to have little or no effect on interictal
epileptiform discharges, regardless of their effectiveness in
controlling seizures.21 This suggests that the effectiveness of an
AED against seizures is not related to its ability to suppress
interictal epileptiform discharges.22 However, Frost el al.10 used a
computer-based assessment of interictal spike morphology to
demonstrate that AED medication could alter epileptic-spike
conﬁgurations, and they found decreased amplitude and duration
and increased sharpness of the spikes in BECTS patients. These
changes were associated with pharmacological seizure controlachieved by phenobarbital and carbamazepine. Based on these
ﬁndings, the authors suggested that the changes in spike
morphology were caused by a critical reduction in the epilepto-
genic neuronal pool that occurred due to effective drug action.10 A
recent study found an improvement, or normalization, of interictal
epileptiform discharges and good seizure control in conjunction
with the preservation of cognitive functioning following OXC
monotherapy in children with BECTS.23 These ﬁndings suggest that
OXC may suppress or improve focal interictal epileptiform
discharges in children with BECTS concomitant with effective
seizure control. In addition to OXC, levetiracetam has also been
shown to decrease interictal epileptiform discharges and to have a
beneﬁcial effect on language function in BECTS patients.24
The hypothesis of Frost et al. may apply to the present study
based on the fact that OXC treatment led to a critical reduction in
the epileptogenic neuronal pool,10 which manifested as decreased
CSD in patients with a good clinical course. However, it should be
noted that Frost et al.10 estimated spike conﬁgurations two weeks
after AED administration with phenobarbital and carbamazepine,
whereas the current patients were reassessed following 6–12
months of OXC therapy. It is possible that various factors, including
the natural course of BECTS, affected the current ﬁndings during
this interval. Considering the higher OXC dose given to the
increased-extent group in this study, the extent of changes in CSD
appear to be associated with an individual’s maturation status with
respect to cortical hyper-excitability, rather than with OXC itself.
Therefore, the action of OXC does not appear to be directly related
to the extent of changes in CSD. To clarify this issue, further
investigation with a control group, such as BECTS patients without
AED medication or with different AEDs, is necessary. Although the
seizure control exerted by OXC may be one of the factors
underlying the reduction in the cortical irritative zone in BECTS
patients, various other factors that could not be investigated may
also affect the natural course of this disease or the extent of
changes in the cortical irritative zone.
This study has several strengths and limitations. To the best of
our knowledge, the current study is the ﬁrst attempt to analyze the
CSD of interictal spikes using LORETA to show whether the extent
of changes in the irritative zone is associated with the clinical
characteristics of BECTS patients. The results of this study
contributes to the debate concerning the relationship between
interictal spike discharges and seizure control in BECTS. However,
the sample size in the present study was too small to allow us to
draw ﬁnal conclusions. Furthermore, the current study design may
not predict the clinical course or ﬁnal prognosis of BECTS patients
because the interval between the two EEGs and the overall clinical
observation period may have been inadequate. Although the
neuropsychological and language outcomes in BECTS patients are
interesting and debatable issues, these functions were not assessed
in this study. The potential for selection bias may be another
limitation of this study because severe patients were excluded and
we only included patients who maintained OXC monotherapy
throughout the observation period. The majority of issues
mentioned above are related to the retrospective format of this
study. Therefore, further work with a prospective format, serial
EEGs, a longer duration of clinical observation, and assessment of
neuropsychology and language is necessary.
5. Conclusion
The present study provides preliminary evidence demonstrating
a relationship between the clinical course and the extent of changes
of the cortical irritative zone in children with BECTS. Distributed
models of current-source analysis using EEG waveforms, including
LORETA, can demonstrate the cortical irritative zones and may be
helpful to better understand the electrophysiological characteristics
J.S. Yeom et al. / Seizure 23 (2014) 560–566566of children with BECTS and to predict the risk of frequent seizures
and drug resistance.
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